Synlogic reports first quarter 2024 financial results

Cambridge, mass., may 14, 2024 (globe newswire) -- synlogic, inc. (nasdaq: sybx), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported financial results for the first quarter 2024 and provided a corporate update.

SYBX Ratings Summary

SYBX Quant Ranking